Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Michael Keith Slevin, Ph.D.


The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. F32GM087059 (SLEVIN, MICHAEL KEITH) Jul 1, 2009 - Dec 31, 2010
    TUT ase mediated degradation of histone mRNA
    Role: Principal Investigator

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Tan KT, Slevin MK, Meyerson M, Li H. Identifying and correcting repeat-calling errors in nanopore sequencing of telomeres. Genome Biol. 2022 08 26; 23(1):180. PMID: 36028900; PMCID: PMC9414165.
    Citations: 1     Fields:    Translation:Cells
  2. Starrett GJ, Thakuria M, Chen T, Marcelus C, Cheng J, Nomburg J, Thorner AR, Slevin MK, Powers W, Burns RT, Perry C, Piris A, Kuo FC, Rabinowits G, Giobbie-Hurder A, MacConaill LE, DeCaprio JA. Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma. Genome Med. 2020 03 18; 12(1):30. PMID: 32188490.
    Citations: 25     Fields:    Translation:HumansCells
  3. Slevin MK, Wollison BM, Powers W, Burns RT, Patel N, Ducar MD, Starrett GJ, Garcia EP, Manning DK, Cheng J, Hanna GJ, Kaye KM, Van Hummelen P, Nag A, Thorner AR, DeCaprio JA, MacConaill LE. ViroPanel: Hybrid Capture and Massively Parallel Sequencing for Simultaneous Detection and Profiling of Oncogenic Virus Infection and Tumor Genome. J Mol Diagn. 2020 04; 22(4):476-487. PMID: 32068070.
    Citations: 4     Fields:    Translation:Humans
  4. MacConaill LE, Burns RT, Nag A, Coleman HA, Slevin MK, Giorda K, Light M, Lai K, Jarosz M, McNeill MS, Ducar MD, Meyerson M, Thorner AR. Unique, dual-indexed sequencing adapters with UMIs effectively eliminate index cross-talk and significantly improve sensitivity of massively parallel sequencing. BMC Genomics. 2018 01 08; 19(1):30. PMID: 29310587.
    Citations: 58     Fields:    Translation:Humans
  5. Su W, Slevin MK, Marzluff WF, Rhoads RE. Synthetic mRNA with Superior Properties that Mimics the Intracellular Fates of Natural Histone mRNA. Methods Mol Biol. 2016; 1428:93-114. PMID: 27236794.
    Citations: 1     Fields:    Translation:HumansCells
  6. Welch JD, Slevin MK, Tatomer DC, Duronio RJ, Prins JF, Marzluff WF. EnD-Seq and AppEnD: sequencing 3' ends to identify nontemplated tails and degradation intermediates. RNA. 2015 Jul; 21(7):1375-89. PMID: 26015596.
    Citations: 14     Fields:    Translation:HumansAnimalsCells
  7. Slevin MK, Meaux S, Welch JD, Bigler R, Miliani de Marval PL, Su W, Rhoads RE, Prins JF, Marzluff WF. Deep sequencing shows multiple oligouridylations are required for 3' to 5' degradation of histone mRNAs on polyribosomes. Mol Cell. 2014 Mar 20; 53(6):1020-30. PMID: 24656133.
    Citations: 31     Fields:    Translation:HumansCells
  8. Jeck WR, Sorrentino JA, Wang K, Slevin MK, Burd CE, Liu J, Marzluff WF, Sharpless NE. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA. 2013 Feb; 19(2):141-57. PMID: 23249747.
    Citations: 1762     Fields:    Translation:HumansAnimalsCells
  9. Su W, Slepenkov SV, Slevin MK, Lyons SM, Ziemniak M, Kowalska J, Darzynkiewicz E, Jemielity J, Marzluff WF, Rhoads RE. mRNAs containing the histone 3' stem-loop are degraded primarily by decapping mediated by oligouridylation of the 3' end. RNA. 2013 Jan; 19(1):1-16. PMID: 23188809.
    Citations: 24     Fields:    Translation:HumansCells
  10. Almeida AD, Wise HM, Hindley CJ, Slevin MK, Hartley RS, Philpott A. The F-box protein Cdc4/Fbxw7 is a novel regulator of neural crest development in Xenopus laevis. Neural Dev. 2010 Jan 04; 5:1. PMID: 20047651.
    Citations: 5     Fields:    Translation:Animals
  11. Slevin MK, Gourronc F, Hartley RS. ElrA binding to the 3'UTR of cyclin E1 mRNA requires polyadenylation elements. Nucleic Acids Res. 2007; 35(7):2167-76. PMID: 17355986; PMCID: PMC1874641.
    Citations: 12     Fields:    Translation:AnimalsCells
  12. Slevin MK, Lyons-Levy G, Weeks DL, Hartley RS. Antisense knockdown of cyclin E does not affect the midblastula transition in Xenopus laevis embryos. Cell Cycle. 2005 Oct; 4(10):1396-402. PMID: 16131839.
    Citations: 3     Fields:    Translation:AnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Slevin's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (108)
Co-Authors (7)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.